Duwat, Lilibeth L.
HRN: 27-37-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2025
CO-AMOXICLAV 625MG (TAB)
06/28/2025
07/07/2025
PO
625 Mg
TID
UTI
Waiting Final Action